203 related articles for article (PubMed ID: 2686417)
1. Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections.
Gaut PL; Carron WC; Ching WT; Meyer RD
Am J Med; 1989 Nov; 87(5A):169S-175S. PubMed ID: 2686417
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections.
Peacock JE; Pegram PS; Weber SF; Leone PA
Am J Med; 1989 Nov; 87(5A):185S-190S. PubMed ID: 2686421
[TBL] [Abstract][Full Text] [Related]
3. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
Fass RJ; Plouffe JF; Russell JA
Am J Med; 1989 Nov; 87(5A):164S-168S. PubMed ID: 2589361
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin (intravenous/oral) versus ceftazidime in lower respiratory tract infections.
Haddow A; Greene S; Heinz G; Wantuck D
Am J Med; 1989 Nov; 87(5A):113S-115S. PubMed ID: 2686410
[TBL] [Abstract][Full Text] [Related]
5. Intravenous ciprofloxacin or ceftazidime in selected infections. A prospective, randomized, controlled study.
Villavicencio J; Asensio de Fernandez ME; Ramirez CA
Am J Med; 1989 Nov; 87(5A):191S-194S. PubMed ID: 2686422
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections.
Gallis HA; Brennan RO; Goodwin SD; Swinney V; Rumbaugh MM; Drew RH
Am J Med; 1989 Nov; 87(5A):176S-180S. PubMed ID: 2686418
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections.
Levine DP; McNeil P; Lerner SA
Am J Med; 1989 Nov; 87(5A):160S-163S. PubMed ID: 2686416
[TBL] [Abstract][Full Text] [Related]
8. Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding.
Sifuentes-Osornio J; Macías A; Amieva RI; Ramos A; Ruiz-Palacios GM
Am J Med; 1989 Nov; 87(5A):202S-205S. PubMed ID: 2686425
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravenous ciprofloxacin in the treatment of serious infections. A comparison with ceftazidime.
Quintero-Perez NP; Andrade-Villaneuva JF; Leon-Garnica G; Bertin-Montano M; Rodriguez-Chagollan JJ; Rodriguez-Noriega E
Am J Med; 1989 Nov; 87(5A):198S-201S. PubMed ID: 2686424
[TBL] [Abstract][Full Text] [Related]
10. Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure.
Gentry LO; Koshdel A
Am J Med; 1989 Nov; 87(5A):132S-135S. PubMed ID: 2686413
[TBL] [Abstract][Full Text] [Related]
11. Use of intravenous ciprofloxacin in difficult-to-treat infections.
Giamarellou H; Galanakis N
Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
[TBL] [Abstract][Full Text] [Related]
13. Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections.
Trenholme GM; Schmitt BA; Spear J; Gvazdinskas LC; Levin S
Am J Med; 1989 Nov; 87(5A):116S-118S. PubMed ID: 2686411
[TBL] [Abstract][Full Text] [Related]
14. Intravenous ciprofloxacin therapy in severe infections.
Gudiol F; Cabellos C; Pallares R; Linares J; Ariza J
Am J Med; 1989 Nov; 87(5A):221S-224S. PubMed ID: 2589364
[TBL] [Abstract][Full Text] [Related]
15. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections.
Khan FA; Basir R
Chest; 1989 Sep; 96(3):528-37. PubMed ID: 2670465
[TBL] [Abstract][Full Text] [Related]
16. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
[TBL] [Abstract][Full Text] [Related]
17. Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections.
Cox CE
Am J Med; 1989 Nov; 87(5A):157S-159S. PubMed ID: 2686415
[No Abstract] [Full Text] [Related]
18. Comparative, double-blind study of intravenous ciprofloxacin and intravenous ceftazidime in serious infection.
Ramirez-Ronda CH; Saavedra S; Rivera-Vazquez CR
Am J Med; 1989 Nov; 87(5A):195S-197S. PubMed ID: 2686423
[No Abstract] [Full Text] [Related]
19. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin versus ceftazidime in skin and soft tissue infections.
Thadepalli H; Mathai D; Chuah SK; Bansal MB
J Chemother; 1989 Feb; 1(1):30-4. PubMed ID: 2656929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
